Abstract
The objective of this study was to investigate the effectiveness of supercritical carbon dioxide (SC CO2) technique for preparing solid complexes between β-cyclodextrin and three local anesthetic agents (benzocaine, bupivacaine, and mepivacaine) by comparing it to more traditional methods such as kneading, co-evaporation, co-grinding, and sealed-heating. Effects of variation of experimental conditions, i.e. temperature, pressure and exposure time, on the products prepared by SC CO2 method were also examined. The products obtained were characterized by powder X-ray diffractometry and Fourier transform infrared spectroscopy, and tested for dissolution properties. Results suggested the possibility of complex formation between β-cyclodextrin and the three anesthetic agents, and indicated that it was influenced by the preparation technique. The co-grinding method was the only one resulting in completely amorphous products for all three drugs. Almost amorphous products, with only limited residual crystallinity, were obtained by co-evaporation and kneading techniques, while SC CO2 and sealed-heating methods gave rise to more crystalline systems. As for the SC CO2 method, temperature (for benzocaine and bupivacaine) or exposure time (for mepivacaine) had significant effects on the solid-state properties of the final products. Dissolution studies indicated that all the examined methods were more effective than the simple physical mixing in improving drug dissolution properties, but the different rank orders observed for the different drugs suggested that there is no general rule for the selection of the most effective preparation method, which depends on the type of drug-Cyd system considered. Nevertheless, in all cases, products obtained by the SC CO2 method showed satisfactory dissolution properties.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10847-006-9192-0/MediaObjects/10847_2006_9192_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10847-006-9192-0/MediaObjects/10847_2006_9192_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10847-006-9192-0/MediaObjects/10847_2006_9192_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10847-006-9192-0/MediaObjects/10847_2006_9192_Fig4_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10847-006-9192-0/MediaObjects/10847_2006_9192_Fig5_HTML.gif)
Similar content being viewed by others
References
Covino, B., Vassallo, H.: Local Anesthetics. Grune and Stratton, New York (1976)
Benumof, J.: Clinical Procedures in Anesthesia and Intensive Care. JB Lippincott, Philadelphia (1992)
Szejtli, J.: Cyclodextrins in Pharmacy, Dordrecht. Kluwer, The Netherlands (1994)
Duchene, D., Wouessidjewe, D.: Pharmaceutical uses of cyclodextrins and derivatives. Drug Dev. Ind. Pharm. 16, 2487–2499 (1990)
Lee, B., Lee, J.: Enhancement of solubility and dissolution rate of poorly water-soluble naproxen by complexation with 2-hydroxypropyl-β-cyclodextrin. Arch. Pharm. Res. 18, 22–26 (1995)
Dhanaraju, M., Kumaran, K., Baskaran, T., Moorthy, M.: Enhancement of bioavailability of griseofulvin by its complexation with beta-cyclodextrin. Drug Dev. Ind. Pharm. 24(6), 583–587 (1998)
Dollo, G., Thompson, D., Le Corre, P., Chevanne, F., Le Verge, R.: Inclusion complexation of amide-typed local anesthetics with β-cyclodextrin and its derivatives. III. Biopharmaceutics of bupivacaine-SBE7-βCD complex following percutaneous sciatic nerve administration in rabbits. Int. J. Pharm. 164(1–2), 11–19 (1998)
Greczy, J., Bruhwyler, J., Scuvee-Moreau, J., Seutin, V., Masset, H., Van Heugen J., Dresse, A., Lejeune, C., Decamp, E., Szente, L., Szejtli, J., Liegeois, J.: The inclusion of fluoxetine into gamma-cyclodextrin increases its bioavailability: behavioural, electrophysiological and pharmacokinetic studies. Psychopharmacology 151(4), 328–334 (2000)
Nagarsenker, M., Meshram, R., Ramprakash, G.: Solid dispersion of hydroxypropyl beta-cyclodextrin and ketorolac: Enhancement of in-vitro dissolution rates, improvement in anti-inflammatory activity and reduction in ulcerogenicity in rats. J. Pharm. Pharmacol. 52, 949–956 (2000)
Kang, J., Kumar, V., Yang, D., Chowdhury, P., Hohl, R.: Cyclodextrin complexation: influence on solubility, stability and cytotoxicity of camptothecin, an antineoplastic agent. Eur. J. Pharm. Sci. 15, 163–170 (2002)
Stanley, T.: New routes of administration and new delivery systems of anesthetics. Anaesthesiolog 38, 665–668 (1988)
Szejtli, J.: Cyclodextrins and their Inclusion Complexes. Akademiai Kiado, Budapest (1982)
Jones, S. Grant, D., Hadgraft, J., Parr, G.: Cyclodextrins in the pharmaceutical sciences. Part I: Preparation, structure and properties of cyclodextrins and cyclodextrin inclusion compounds. Acta Pharm. Technol. 30, 213–223 (1984)
Irie, T., Uekama K.: Protection against the photosensitized skin irritancy of chlorpromazine by cyclodextrin complexation. J. Pharmacobiol. Dyn. 8(9), 788–791 (1985)
Mura, P., Faucci, M., Bettinetti, G.: The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-β-cyclodextrin. Eur. J. Pharm. Sci. 13, 187–194 (2001)
Cirri, M., Rangoni, C., Maestrelli, F., Corti, G., Mura, P.: Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes. Drug Dev. Ind. Pharm. 31(7), 697–707 (2005)
Mura, P., Furlanetto, S., Cirri, M., Maestrelli, F., Corti, G., pinzauti, S.: Interaction of naproxen with ionic cyclodextrins in aqueous solution and in the solid state. J. Pharm. Biomed. Anal. 37, 987–994 (2005)
Veiga, M., Merino, M., Cirri, M., Maestrelli, F., Mura, P.: Comparative study on triclosan interactions in solution and in the solid state with natural and chemically modified cyclodextrins. J. Incl. Phenom. 53(1), 77–83 (2005)
Hirayama, F., Uekama, K.: Cyclodextrins and their Industrial Uses. Editions de Santé, Paris (1987) pp. 133
Blanco, J., Vila-Jato, J.L., Otero, F., Anguiano, S.: Influence of the method of preparation on inclusion complexes of naproxen with different cyclodextrins. Drug Dev. Ind. Pharm. 17, 943–957 (1991)
Mura, P., Adragna E., Rabasco, A., Moyano, J., Perez-Martinez, J., Arias, M., Gines, J.: Effects of the host cavity size and the preparation method on the physicochemical properties of ibuproxam-cyclodextrin systems. Drug Dev. Ind. Pharm. 25, 279–287 (1999a)
Mura, P., Faucci M.T., Manderioli A., Bramanti G.: Influence of the preparation method on the physicochemical properties of binary systems of econazole with cyclodextrins. Int. J. Pharm. 193, 85–95 (1999b)
Mura, P., Faucci, M.T., Parrini, P.L., Furlanetto, S., Pinzauti, S.: Influence of the preparation method on the physicochemical properties of ketoprofen-cyclodextrin binary systems. Int. J. Pharm. 179, 117–128 (1999c)
Kiran, E., Brennecke J.: Supercritical Fluid Engineering Science, ACS Symposium Series 514, American Chemical Society, Washington DC (1993)
Van Hees, T., Piel, G., Evrard, B., Otte, X., Thunus, L., Delattre, L.: Application of supercritical carbon dioxide for the preparation of a piroxicam-β-cyclodextrin inclusion compound. Pharm. Res. 16, 1864–1870 (1999)
Junco, S. Casimiro T., Ribeiro, N., da Ponte, M.N., Cabral Marques, H.: A comparative study of naproxen-beta cyclodextrin complexes prepared by conventional methods and using supercritical carbon dioxide. J. Incl. Phenom. 44(1–4), 117–121 (2002)
Charoenchaitrakool, M., Dehghani, F., Foster, R.F.: Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-β-cyclodextrin. Int. J. Pharm. 239(1–2), 103–112 (2002)
Lai, S., Locci E., Piras, A., Porcedda, S., Lai, A., Marongiu B.: Imazalil-cyclomaltoheptaose (β-cyclodextrin) inclusion complex: Preparation by supercritical carbon dioxide and 13C CPMAS and 1H NMR characterization. Carbohydr. Res. 338(21), 2227–2232 (2003)
Al-Marzouqi A., Shehatta, I., Jobe, B., Dowaidar, A.: Phase solubility and inclusion complex of itraconazole with β-cyclodextrin using supercritical carbon dioxide. J. Pharm. Sci. 95, 292–304 (2006)
Shehatta, I., Al-Marzouqi, A., Jobe, B., Dowaidar, A.: Enhancement of aqueous solubility of itraconazole by complexation with cyclodextrins using supercritical carbon dioxide. Can. J. Chem. 83(10), 1833–1838 (2005)
de Jong, R.H.: Local Anestethics. Springfield, Illinois (1994)
Strichartz, G.R., Sanchez, V., Arthue, R., Chafetz, R., Martin, D.: Fundamental properties of local anesthetics. II. Measured octanol:buffer partition coefficients and pK(a) values of clinically used drugs. Anest. Analg. 71(2), 158–170 (1990)
Dollo, G., LeCorre, P., Chevanne, Le Verge, R.: Inclusion complexation of amide-typed local anaesthetics with ß-cyclodextrin and its derivatives. I. Physicochemical characterization. Int. J. Pharm. 131(2), 219–228 (1996)
Pinto, L., Fraceto L., Santana, M., Pertinhez, T., Oyama Junior, S., de Paula, E.: Physico-chemical characterization of benzocaine-β-cyclodextrin inclusion complexes. J. Pharmaceut. Biomed. 39(5), 956–963 (2005)
Hassan, A., Tang, Y., Ayres, J.: Itraconazole formation using supercritical carbon dioxide. Drug Dev. Ind. Pharm. 30(10), 1029–1035 (2004)
Khan, K.A.: The concept of dissolution efficiency. J. Pharm. Pharmacol. 27(1), 48–49 (1975)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Al-Marzouqi, A., Jobe, B., Corti, G. et al. Physicochemical characterization of drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques. J Incl Phenom Macrocycl Chem 57, 223–231 (2007). https://doi.org/10.1007/s10847-006-9192-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10847-006-9192-0